<DOC>
	<DOCNO>NCT00673075</DOCNO>
	<brief_summary>This study do see blood pressure lower effect approve drug nebivolol comparable another approved drug carvedilol treatment hypertension patient coronary artery disease .</brief_summary>
	<brief_title>The Effect Nebivolol Hypertensive Patients With Coronary Artery Disease</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Carvedilol</mesh_term>
	<mesh_term>Nebivolol</mesh_term>
	<criteria>Male female ambulatory outpatient 18 85 age screen Coronary artery disease define : status post myocardial infarction ( heart attack ) great 14 day post event upper time limit ( followed stress test additional imaging ( echocardiographic nuclear ) within 12 month prior enrollment ) and/or angiographic evidence one major coronary artery narrow great 50 % and/or history percutaneous surgical coronary revascularization great 4 month procedure time enrollment . Qualifying blood pressure criterion study entry randomization Willing adhere exercise stress ( treadmill ) test Unstable angina within 7 day screen Potential coronary surgical/intervention within next 6 month Have form secondary hypertension Have history hypersensitivity nebivolol , metoprolol , carvedilol , beta blocker</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2010</verification_date>
	<keyword>carvedilol</keyword>
	<keyword>Coreg ( TM )</keyword>
	<keyword>hypertension</keyword>
	<keyword>blood pressure</keyword>
	<keyword>coronary artery disease</keyword>
	<keyword>Nebivolol</keyword>
	<keyword>BYSTOLIC ( TM )</keyword>
</DOC>